| Schedule of Computation of Basic and Dilutive Net Loss Per Share |
The computation of basic and dilutive
net loss per share attributable to common stockholders for the six months ended June 30, 2025 and 2024, are as follows:
| | |
Three Months Ended
June 30, | | |
Six Months Ended
June 30, | |
| | |
2025 | | |
2024 | | |
2025 | | |
2024 | |
| Basic: | |
| | |
| | |
| | |
| |
| Numerator: | |
| | |
| | |
| | |
| |
| Net loss attributable to common shareholders | |
$ | (7,410,858 | ) | |
| (7,278,070 | ) | |
$ | (3,111,806 | ) | |
$ | (13,297,064 | ) |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted-average common shares outstanding | |
| 38,813,663 | | |
| 21,327,643 | | |
| 37,621,401 | | |
| 20,926,336 | |
| Net loss per share – basic: | |
| (0.19 | ) | |
| (0.34 | ) | |
$ | (0.08 | ) | |
$ | (0.64 | ) |
| Diluted: | |
| | | |
| | | |
| | | |
| | |
| Numerator: | |
| | | |
| | | |
| | | |
| | |
| Net income (loss) attributable to common and common equivalent shareholders | |
| (7,410,858 | ) | |
| (7,278,070 | ) | |
| (3,111,806 | ) | |
| (13,297,064 | ) |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted-average common stock outstanding | |
| 38,813,663 | | |
| 21,327,643 | | |
| 37,621,401 | | |
| 20,926,336 | |
| Stock options, RSUs, warrants, Earn-Out Liability, and convertible notes outstanding to purchase shares of common stock | |
| - | | |
| - | | |
| - | | |
| - | |
| Total common and common equivalent shares outstanding | |
| 38,813,663 | | |
| 21,327,643 | | |
| 37,621,401 | | |
| 20,926,336 | |
| Net loss per share – diluted: | |
| (0.19 | ) | |
| (0.34 | ) | |
$ | (0.08 | ) | |
$ | (0.64 | ) |
|
| Schedule of Net Income (Loss) Per Share-Diluted Including Anti-Dilutive |
The weighted average potential shares of common
stock that were excluded from the calculation of net income (loss) per share-diluted for the periods presented because including them
would have been anti-dilutive consisted of the following:
| | |
Three Months Ended
June 30, | | |
Six Months Ended
June 30, | |
| | |
2025 | | |
2024 | | |
2025 | | |
2024 | |
| Stock options outstanding to purchase shares of common stock and RSUs | |
| 4,299,028 | | |
| - | | |
| 4,222,367 | | |
| - | |
| Public and Private Warrants | |
| 11,799,851 | | |
| - | | |
| 11,799,851 | | |
| - | |
| Convertible Notes | |
| 184,531 | | |
| - | | |
| 92,265 | | |
| - | |
The weighted average potential shares of common stock that were excluded
from the calculation of net loss per share-diluted because the performance or market conditions associated with these awards were not
met are as follows for the periods presented:
| | |
Three Months Ended
June 30, | | |
Six Months Ended
June 30, | |
| | |
2025 | | |
2024 | | |
2025 | | |
2024 | |
| Earn-Out Liability | |
| 4,500,000 | | |
| - | | |
| 4,500,000 | | |
| - | |
|